2nd Quarter - Report

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Personalized medicine regulation, CMS coverage of personalized medicines and diagnostics & PAMA implementation, CER and Genomics, FDA regulation of personalized medicine, regulation of laboratory developed tests, 21st Century Cures Initiative, Healthier Americans Initiative, Precision Medicine Initiative and Cancer Moonshot task-force, medical device and prescription drug user-fees

LobbyistCovered position, as disclosed
AMY M MILLER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.